Breast cancer in men;Cancer du sein chez l'homme

Presse Medicale

Volumn 36, Issue 12 III, 2007, Pages 1919-1924

  Beyrouti, Mohamed Issam ^a   Beyrouti, Rahma ^a   Beyrouti, Ramez ^a   Ben Amar, Mohamed ^a   Affes, Nejmeddine ^a   Frikha, Foued ^a   Abid, Mohamed ^a   Mnif, Héla ^a   Ayadi, Lobna ^a   Ghorbel, Ali ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMASINE; ESTROGEN; ESTROGEN RECEPTOR; EXEMESTANE; LETROZOLE; PROGESTERONE RECEPTOR; PROLACTIN; TAMOXIFEN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ASPIRATION CYTOLOGY; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER ADJUVANT THERAPY; CANCER STAGING; CARCINOMA IN SITU; CLINICAL EXAMINATION; ECHOGRAPHY; FAMILY HISTORY; HORMONAL THERAPY; HORMONE METABOLISM; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MAMMOGRAPHY; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PROGNOSIS; SHORT SURVEY; ADOLESCENT; ADULT; AGE; AGED; BIOPSY; BREAST; BREAST TUMOR; CHILD; COMPARATIVE STUDY; ECHOMAMMOGRAPHY; FEMALE; INCIDENCE; MASTECTOMY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; REVIEW;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MAMMOGRAPHY; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; PROGNOSIS; ULTRASONOGRAPHY, MAMMARY;

EID: 36249009560     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.03.033     Document Type: Short Survey

References (59)

1. El Hajjam M., Khaiz D., Benider A., Lakhloufi A., Abi F., Kahlain A., et al. Cancer du sein chez l'homme. À propos de 50 observations. J Chir (Paris) 132 (1995) 131-136
2. Hodgson N.C., Button J.H., Franceschi D., Moffat F.L., and Livingstone A.S. Male breast cancer: is the incidence increasing?. Ann Surg Oncol 11 (2004) 751-755
3. Nance K.V., and Reddick R.L. In situ and infiltrating lobular carcinoma of the male breast. Hum Pathol 20 (1989) 1220-1222
4. Nectoux J., and Parkin D.M. L'épidémiologie du cancer du sein chez l'homme. Bull Cancer 79 (1992) 991-998
5. Beyrouti M.I., Kharrat K., Affes N., Ben Ali I., Abbes I., Frikha F., et al. Le cancer du sein chez l'homme. Tun Med. 81 (2003) 48-54
6. Maalej M., Frikha H., Ben Salem S., Daoud J., Bouaouina N., Ben Abdallah M., et al. Breast cancer in Tunisia: clinical and epidemiological study. Bull Cancer 86 (1999) 302-306
7. Hali F., Chiheb S., El Ouazzani T., and Lakhdar H. Male breast cancer in Morocco. Ann Dermatol Venereol 129 (2002) 699-702
8. Anan K., Mitsuyama S., Nishihara K., Abe Y., Iwashita T., Ihara T., et al. Breast cancer in Japanese men : does sex affect prognosis?. Breast Cancer 11 (2004) 180-186
9. Buzdar A.U. Breast cancer in men. Oncology 17 (2003) 1361-1364 (Williston Park)
10. Goss P.E., Reid C., Pintilie M., Lim R., and Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 85 (1999) 629-639
11. Karlsson C.T., Malmer B., Wiklund F., and Gronberg H. Breast cancer as a second primary in patients with prostate cancer--estrogen treatment or association with family history of cancer?. J Urol 176 (2006) 538-543
12. Benchellal Z., Wagner A., Harchaoui Y., Huten N., and Body G. Male breast cancer: 19 case reports. Ann Chir 127 (2002) 619-623
13. Cutuli B.F., Velten M., Forentz P., Hedelin G., Horiot J.C., Pavy J.J., et al. Cancer du sein chez l'homme : 126 observations. Presse Med 22 (1993) 463-466
14. Contesso G., Mathieu M.C., and Guinebretiere J.M. Anatomie pathologique des cancers du sein. Rev Prat 48 (1998) 29-35
15. Esteller M., Silva J.M., Dominguez G., Bonilla F., Matias-Guiu X., Lerma E., et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92 (2000) 564-569
16. Lubinski J., Phelan C.M., Ghadirian P., Lynch H.T., Garber J., Weber B., et al. Cancer variation associated with the position of the mutation in the BRCA2 gene. Fam Cancer 3 (2004) 1-10
17. Palli D., Masala G., Mariani-Costantini R., Zanna I., Saieva C., Sera F., et al. A gene environment interaction between occupation and BRCA1/BRCA2. Eur J Cancer 40 (2004) 2474-2479
18. Gordon D.J., Chin K.H., Budny P.G., and Taylor A.R. Male breast cancer in World War II aviation: a case report and review. Breast 12 (2003) 156-157
19. Giordano S.H., and Hortobagyi G.N. Leuprolide acetate plus aromatase inhibition for male breast cancer. J Clin Oncol 24 (2006) 42-43
20. Volpe C.M., Raffetto J.D., Collure D.W., Hoover E.L., and Doerr R.J. Unilateral male breast masses : cancer risk and their evaluation and management. Am Surg 65 (1999) 250-253
21. Olsson H. Estrogen receptor content in malignant breast tumors in men a review. J Mammary Grand Biol Neoplasia. 5 (2000) 283-287
22. Milham S. A cluster of male breast cancer in office workers. Am J Ind Med 46 (2004) 86-87
23. El-Tamer M.B., Komenaka I.K., Troxel A., Li H., Joseph K.A., Ditkoff B.A., et al. Men with breast cancer have better disease-specific survival than women. Arch Surg 139 (2004) 1079-1082
24. Guenel P., Cyr D., Sabroe S., Lynge E., Merletti F., Ahrens W., et al. Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study. Cancer Causes Control 15 (2004) 571-580
25. - Trojani M, Mac Grogan G. Anatomie pathologique du sein. Encycl Med Chir Paris, Gynécologie, 1998 ; 810B10.
26. Takeuchi H., and Shiraska C. Clinicopathological study of Japanese male breast carcinoma. Breast Cancer 10 (2003) 249-253
27. Nesland J.M., Ottestad L., Heikillia R., Holm R., Tveit K., and Borresen A.L. C-erbB-2 protein and neuroendocrine expression in breast carcinoma. Anticancer Res 1 (1991) 161-168
28. Odile D., and Meena B. Diffuse neuroendocrine différenciation in a morphologically composite mammary infiltrating ductal carcinoma : a case report and review of the literature. Arch Path Lab Med. 127 (2003) 131-134
29. Pappo I., Wasserman I., and Halevy A. Ductal carcinoma in situ of the breast in men: a review. Clin. Breast Cancer 6 4 (2005) 310-314
30. Giard S. Carcinoma in situ. Encycl Med Chir. Paris, Gynécologie, 2001 ; 865 A30.
31. Donegan W.L., and Redlich P.N. Breast cancer in men. Surg Clin North Am 76 (1996) 343-363
32. Cimmino V.M., Degnim A.C., Sabel M.S., Diehl K.M., Newman L.A., and Chang A.E. Efficacy of sentinel lymph node biopsy in male breast cancer. J Surg Oncol 86 (2004) 74-77
33. Gennari R., Scelsi M., Greco B., and Costa A. Complete nodal staging in male breast cancer. (Biopsy of axillary and internal mammary sentinel node). J Exp Clin Cancer Res 23 (2004) 163-165
34. De Cicco C., Baio S.M., Veronesi P., Trifiro G., Ciprian A., Vento A., et al. Sentinel node biopsy in male breast cancer. Nucl Med Commun 25 (2004) 139-143
35. Clark J.L., Nguyen P.L., Jaszcz W.B., Jatoi A., and Niehans G.A. Prognostic variables in male breast cancer. Am Surg 66 (2000) 502-511
36. Muir D., Kanthan R., and Kanthan S.C. Male versus female breast cancers. A population-based comparative immunohistochemical analysis. Arch Pathol Lab Med 127 (2003) 36-41
37. Svrcek M., and Sabourin J.C. Confrontation immunohistochimique et analyse génotypique de tumours. Première partie : quel futur pour le diagnostic immunohistochimique des cancers?. Ann Pathol 22 (2002) 102-112
38. Yamashita H., Nishio M., Toyama T., Sugiura H., Zhang Z., Kobayashi S., et al. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer. Breast Cancer Res 6 (2004) 24-30
39. Menard S., Casalini P., Campiglio M., Pupa S., Agresti R., and Tagliabue E. HER2 over expression in various tumor types, focussing on its relationship to the development of invasive breast cancer. Ann Oncol 12 (2001) 515-519
40. Niveditha S.R., and Bajaj P. Vimentin expression in breast carcinomas. Indien J Pathol. Microbiol. 46 (2003) 579-584
41. Giordano S.H., Buzdar A.U., and Hortobagyi G.N. Breast cancer in men. Intern Med 137 (2002) 678-684
42. Garbay J.R., Hacene K., Tubiana-Hulin M., Yacoub S., and Rouesse J. Clinical prognostic factors in breast cancer. Retrospective study of 5609 cases. Bull Cancer 81 (1994) 1078-1084
43. Chen L., Chantra P.K., Larsen L.H., Barton P., Rohitopakarn M., Zhu E.Q., et al. Imaging characteristics of malignant lesions of the male breast. Radiographics 26 (2006) 993-1006
44. Brenner R.J., Weitzel J.N., Hansen N., and Boasberg P. Screening-detected breast cancer in a man with BRCA2 mutation: case report. Radiology 230 (2004) 553-555
45. Westenend P.J. Care needle biopsy in male breast lesions. J Clin Pathol 56 (2003) 863-865
46. Gennari R., Curigliano G., Jereczek-Fossa B.A., Zurrida S., Renne G., Intra M., et al. Male breast cancer: a special therapeutic problem. Anything new?. Int J Oncol 24 (2004) 663-670
47. Giordano S.H., Valero V., Buzdar A.U., and Hortobagyi G.N. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 25 (2002) 235-237
48. Kaufmann M., and Rody A. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?. Eur J Obstet Gynecol Reprod Biol 126 (2006) 146-154
49. Milla-Santos A., Milla L., Portella J., Rallo L., Pons M., Rodes E., et al. Anastrozole versus tamoxifen as first-line therapy in postmenopausal patients with hormone-dependent advanced breast cancer: a prospective, randomized, phase III study. Am J Clin Oncol 26 (2003) 317-322
50. Brodie A., Sabnis G., and Jelovac D. Aromatase and breast cancer. J Steroid Biochem Mol Biol. 102 1-5 (2006) 97-102
51. Bagley C.S., Wesley M.N., Young R.C., and Lippman M.E. Adjuvant chemotherapy in males with cancer of the breast. Am J Clin Oncol 10 (1987) 55-60
52. Patel II H.Z., Buzdar A.U., and Hortobagyi G.N. Role of adjuvant chemotherapy in male breast cancer. Cancer 64 (1989) 1583-1585
53. Italiano A., Largillier R., Marcy P.Y., Foa C., Ferrero J.M., Hartmann M.T., et al. Complete remission obtained with letrozole in a man with metastatic breast cancer. Rev Med Interne 25 (2004) 323-324
54. Bines J., Goss B., Hussong J., Chmiel J., Yeldandi A.V., Gradishar W.J., et al. c-erbB2 and p53 overexpression as predictors of survival in patients with male breast cancer. Proc Annu Meet Am Soc Clin Oncol. 16 (1997) 558
55. Fitzgibbons P.L., Page D.L., Weaver D., Thor A.D., Allred D.C., Clark G.M., et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 966-978
56. Treilleux J., and Bremond A. Pronostic des cancers du sein. Encycl Med Chir. Gynecologie 865 (2002) F20
57. William L., Donergan M.D., Philip N., and Redilich M.D. Carcinoma of the breast in Males. A multinstitutional Surgery. Cancer 83 (1998) 498-509
58. Barlund M., Kuukasjarvi T., Syrjakoski K., Auvinen A., and Kallioniemi A. Frequent amplification and overexpression of CCND1 in male breast cancer. Int J Cancer 111 (2004) 968-971
59. Piekarski J.H., and Jeziorki A. Breast neoplasm in men and women prognosis comparison. Wiad Lek 56 (2003) 239-243